Loading...
•
Dec 31, 2019
Evolent Health Q4 2019 Earnings Report
Evolent Health's Q4 2019 financial results were announced, revealing a revenue increase of 22.5% and strategic advancements.
Key Takeaways
Evolent Health reported a 22.5% increase in GAAP revenue, reaching $236.5 million for the fourth quarter of 2019. The company's net loss attributable to common shareholders was $(198.1) million, which included a non-cash goodwill impairment of $199.8 million. Adjusted EBITDA stood at $8.2 million, and the company had approximately 3.7 million lives on its platform.
GAAP revenue increased by 22.5% to $236.5 million.
Net loss attributable to common shareholders was $(198.1) million, impacted by a non-cash goodwill impairment.
Adjusted EBITDA reached $8.2 million.
Approximately 3.7 million lives were on the platform.
Evolent Health
Evolent Health
Forward Guidance
For the full year 2020, revenue is expected to be in the range of approximately $935.0 million to $985.0 million. Adjusted EBITDA for the full year is expected to be $24.0 million to $32.0 million. For the three months ended March 31, 2020, revenue is expected to be in the range of approximately $233.5 million to $245.5 million. Adjusted EBITDA is expected to be in the range of approximately $2.0 million to $5.0 million.